|
Search
Collections
Benchmarks
Upload document
Indication
Severe/Very Severe COVID-19 Illness
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 product
Clinical trial
Managed Access Programs for INC424, Ruxolitinib
Status:
Product
Ruxolitinib
